SPLITOAK STRATEGIES LLC

Lobbying for CARIS SCIENCE INC · Providing precision medicine services to patients battling aggressive cancers.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $40,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; S 2355, Patients Deserve Price Tags

Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.